Articles tagged with Inflammation
Research suggests that disengaging from impossible goals can lower bodily inflammation levels, a potential risk factor for diseases like diabetes and heart disease. Setting new goals after giving up on an important one can also improve mental health by increasing purpose and mastery.
A new study reveals that mast cells not only cause allergic reactions but also help reduce skin damage and inflammation from sun exposure or poison oak. The discovery opens up new possibilities for treating allergies and other conditions.
Researchers at OHSU demonstrate a new technique using contrast-enhanced ultrasound and targeted microbubbles to detect inflammatory processes leading to atherosclerosis. This could enable early detection and prevention of coronary heart disease and stroke, two of the nation's most lethal diseases.
A study found that ibuprofen treatment improved cognitive function in rats with chronic liver failure by reducing inflammation and normalizing a key brain pathway. The results suggest a potential therapeutic utility of decreasing inflammation in treating hepatic encephalopathy.
A new triple combination therapy has been successful in abolishing adverse autoimmunity against insulin-producing cells in a mouse model of Type 1 diabetes. The treatment eliminated inflammation and restored normal blood glucose levels by blocking its effects on fat and muscle tissues.
A recent study by University of Illinois researchers found that individuals with better parasympathetic tone had lower levels of inflammation, as measured by C-reactive protein (CRP). Exercise has been shown to improve parasympathetic tone, leading to a quicker heart-rate recovery after physical activity.
A woman's symptoms of colitis emerged 27 years after she left the country where she was infected with a parasitic worm. Analysis revealed larvae of Strongyloides stercoralis caused her digestive issues, highlighting the importance of considering this rare disease in patients with cellular immune defects.
New data demonstrates that MabThera effectively relieves RA symptoms and improves remission rates with subsequent courses of therapy. The safety profile remains consistent even after seven courses of treatment, providing confidence for physicians to make informed treatment decisions.
Scientists at University of Bonn discover endocannabinoids regulate inflammation processes. Extracts from hemp plant also show anti-inflammatory effects, potentially leading to new treatments.
Researchers at Jefferson Medical College found that a natural substance secreted by fat cells can protect blood vessels from inflammation, a factor in heart disease. Harnessing adiponectin's properties may someday help protect against blood vessel damage in patients with obesity and diabetes.
Research suggests that people with high levels of inflammation in their blood are more likely to develop Alzheimer's disease. The study of over 600 participants found that those with elevated cytokines were nearly twice as likely to develop the disease.
A study at the University of Pittsburgh School of Medicine found that green tea's catechins protected normal and cancerous bladder cells from inflammation. The findings suggest herbal supplements from green tea could be a treatment option for various bladder conditions.
A new study suggests that balancing omega-6 and omega-3 fatty acid intake can reduce the risk of clinical depression and certain inflammatory diseases. Participants with higher levels of omega-6 and symptoms of depression had elevated markers of inflammation.
Researchers at Yale University developed a novel method to detect abnormal proteins in amniotic fluid, indicating a higher risk of delivering prematurely. The study found that these proteins are associated with inflammation and infection, allowing for earlier detection and treatment of neonatal infections.
Researchers found graded associations between psychosocial factors and inflammatory markers, with cynical distrust strongly linked to increased inflammation. The study suggests that behaviors such as smoking may mediate the link between psychosocial factors and cardiovascular disease risk.
A new study by Harvard researchers has linked periodontal disease to an increased risk of pancreatic cancer. Men with periodontal disease had a 63% higher risk of developing the disease compared to those without it, after adjusting for other factors.
Researchers developed a score based on protein markers to predict inflammation in amniotic fluid, associated with preterm delivery and infant sepsis. The 'Mass Restricted' (MR) score showed promise in identifying women at risk of preterm birth and babies with suspected or confirmed sepsis.
Research suggests that inflammatory genes may play a key role in salt-sensitive hypertension, which affects nearly one-third of Americans. The study investigates the connection between stress, inflammation, and sodium handling, with potential therapeutic implications for high blood pressure management.
Researchers have discovered a genetic risk factor for inflammatory bowel disease (IBD) that may confer protection against Crohn's disease and ulcerative colitis. The study highlights a major inflammatory pathway and identifies potential targets for therapies, including the manipulation of IL-23 pathway.
A clinical trial is underway to assess the effectiveness of Reparagen in treating moderate osteoarthritis, with findings that it 'silences' genes promoting joint damage while activating the repair gene IGF-1.
Researchers found that treating newly diagnosed GCA patients with high-dose intravenous steroids reduced long-term need for prednisone and improved recovery. Patients who received the initial treatment had fewer relapses and were able to significantly reduce their daily dose of prednisone after a year.
Researchers at the University of Pennsylvania School of Medicine have found that deleting an inflammation enzyme in mice slowed the development of atherosclerosis. The study suggests that a new class of nonsteroidal anti-inflammatory drugs (NSAIDs) may benefit the heart and reduce its risk of disease.
Researchers found that high salivary melatonin levels may be associated with lower periodontal disease severity, as measured by the community periodontal index score. This suggests that melatonin's antioxidant properties may help protect against inflammation and oxidative damage in the oral cavity.
Scientists from Boston University created a mouse model with reduced inflammation, which may lead to new treatments for conditions like arthritis and Crohn's disease. The study found that the LITAF transcription factor controls inflammation through a different pathway than the NF-kB regulator.
Researchers at Mayo Clinic have discovered an association between allergic rhinitis and the development of Parkinson's disease. The study found that people with allergic rhinitis are 2.9 times more likely to develop Parkinson's, highlighting a potential link between inflammation and the disease.
Tiny airborne particles, similar to nanoparticles, follow a rapid and efficient pathway from the nasal cavity to various regions of the brain in rats. The study found increased gene expression signaling inflammation and cellular stress response, but it is unclear if ultrafine particle buildup causes brain damage.
A study published in the Journal of Clinical Investigation found that a fatty acid binding protein called aP2 plays a crucial role in controlling inflammation in asthma. The research suggests that blocking aP2 function may be a novel approach for asthma treatment and other inflammatory lung diseases.
Researchers found that AAS abusers had statistically significant levels of gingival enlargement compared to non-users, requiring a gingivectomy for many cases. Gingival inflammation was also higher in the user group, suggesting potential long-term effects on periodontal health.
New research suggests targeting affected nerves and spinal cords may provide relief from chronic neuropathic pain. The study found changes in spinal cord neurons after sciatic nerve constriction injury, but the exact mechanisms remain unclear.
Researchers at Rutgers University propose a new approach to combat clogged arteries by attacking how bad cholesterol triggers inflammation and causes plaque buildup. Their nanolipoblockers, or NLBs, compete with oxidized LDL for macrophage attention, cutting accumulation by up to 75 percent.
Researchers found that stretching increases resistance to injury by producing nitric oxide, but inhibiting NO production eliminates protection. The study suggests that understanding how stretching works can help prevent muscle injuries and promote healthy aging.
A study published at the AACR annual meeting found that a history of allergies and asthma significantly reduces the risk of developing brain tumors. Individuals with allergies or asthma had a lower risk of glioblastoma, mid-grade anaplastic astrocytoma, and low-grade gliomas compared to those without these conditions.
A randomized study of 140 COPD patients found that a combination therapy significantly reduced inflammatory cells and improved lung function. The treatment, salmeterol/fluticasone propionate, decreased inflammation by 36% and showed improvements in lung function similar to other anti-inflammatory treatments.
Researchers developed RGD peptide liposomes to deliver dexamethasone phosphate directly to VECs at sites of inflammation, reducing arthritis severity and disease progression. The study demonstrates the potential of targeted liposomal therapy for treating rheumatoid arthritis.
Researchers used PET scans to monitor artificially induced lung inflammation in healthy volunteers, allowing for less invasive testing of potential anti-inflammatory drugs. The new imaging process may help diagnose inflammatory lung diseases and improve clinical trials.
Researchers have developed a new test that can predict fetal complications from intrauterine inflammation/infection, providing faster results and higher accuracy than traditional methods. The test uses proteomic profiling of amniotic fluid to identify biomarkers of inflammation, allowing for early intervention and potentially reducing ...
A new proteomic profiling test can detect preterm birth risk in 20-30 minutes, predicting delivery times of four days or less. The test uses fresh amniotic fluid samples and is faster than current methods.
Researchers found that high white blood cell counts were associated with an increased risk of cancer mortality, even after controlling for other factors. The association was strongest for lung cancer and suggested that aspirin may have a greater protective effect against cancer for those with high WBC counts.
Researchers at UVA Health System are investigating a novel approach to combat chronic kidney disease by targeting inflammation with adenosine drugs. Preliminary results show promising decreases in inflammation, urinary protein loss, and kidney scarring.
Researchers found that exposure to fine particle air pollution and a high-fat diet together contribute to the development of atherosclerosis in laboratory mice. The study suggests that even low concentrations of air pollution may accelerate the progression of atherosclerosis, particularly among those with risk factors.
Researchers at Children's Hospital of Philadelphia developed a novel technique to attach therapeutic genes to bare metal stents, reducing inflammation and restenosis. The study used animal models and found significantly lower restenosis with the new stents compared to conventional ones.
Research suggests that low-dose carbon monoxide can act as an anti-inflammatory agent, reducing the production of interleukin-12 and short-circuiting disease-causing inflammation in ulcerative colitis. Non-smokers with inflammatory bowel disease should not rely on smoking to alleviate symptoms.
Researchers found that patients with severe periodontitis have elevated levels of small-dense LDL in their blood, which increases the risk of heart disease. The study also suggests that platelet activating factor acetylhydrolase may play a role in this increased risk.
A study using mouse models found that B. pertussis toxin inhibits neutrophil recruitment, delaying antibody-mediated clearance and allowing repeated infection. Another study identified thrombospondin-1 as a novel mediator of ischemic damage in the kidney, which may be a target for drugs to reduce kidney failure risk.
A recent study by Mayo Clinic researchers suggests that sinusitis is a leading cause of chronic cough, affecting an estimated 23 million Americans annually. The study found that 37.1% of patients suspected of having sinusitis were ultimately diagnosed with the condition as the cause of their chronic cough.
Researchers have discovered that eating fatty foods can dampen inflammation in the gut by stimulating the production of cholecystokinin, a hormone that sends signals to the brain and immune cells. This process may provide a way to reduce inflammatory complications after surgery.
Researchers have discovered the SEPS1 (Selenoprotein S) gene's role in inflammation, which is a common component of many human disorders. The study found that a genetic variation in the SEPS1 gene can lead to higher levels of inflammation and increased risk of diseases like cardiovascular disease and Type 2 diabetes.
Researchers have discovered a synthetic protein, P60 PLAD, that powerfully inhibits arthritis symptoms in mice. The study suggests that this protein could represent an advantage over current treatments, which directly block tumor necrosis factor alpha by binding to both TNFRs and inhibiting beneficial actions mediated by TNFR-2.
A study of 32 patients with heart failure found that those experiencing depression had nearly twice the levels of tumor necrosis factor alpha (TNF-alpha) in their blood. This increase was associated with worsened heart function, as TNF-alpha promotes inflammation and reduces the heart's ability to pump blood effectively.
Researchers found that 97% of patients achieved control over ocular inflammation after one month of treatment with the new drug. Additionally, 82% were able to taper their dose of steroid prednisone without experiencing increased side effects.
Researchers discovered that CD11b-positive macrophages play a crucial role in the development of lymphangiogenesis in the cornea during inflammatory conditions. These macrophages transform into endothelial cells or stimulate the division of existing lymphatic cells, leading to the formation of new lymph vessels.
A new protein called ABIN-1 has been discovered that can prevent the death of liver cells in people with hepatitis. Researchers have shown that an extra dose of ABIN-1 provides a double protective effect against inflammation and cell death, offering new hope for treating liver disorders.
Cholesterol crystals can expand and burst in arteries, triggering a natural clotting process that shuts down the artery. This discovery adds another dimension to the inflammation theory, suggesting that the crystallization of cholesterol is a key factor in cardiovascular disease.
A new imaging technology has shown promise in detecting pancreatic inflammation in type 1 diabetes, allowing for early prediction of disease progression and response to treatment. The technique uses magnetic nanoparticles and MRI to identify inflamed pancreatic islets, potentially reducing the need for invasive biopsies.
Researchers at the University of Rochester Medical Center will investigate how to manipulate intracellular signaling pathways to reduce inflammation in blood vessels, a key factor in heart disease. The team aims to develop new treatments by targeting proteins involved in the inflammatory response.
Researchers at Washington University School of Medicine found that cathepsin G regulates neutrophil secretion of inflammatory chemicals, leading to tissue and cartilage damage in joints. Inhibiting this enzyme has attractive potential as a therapeutic target for treating arthritis.
Researchers discovered a protein in the eye that prevents the immune system from responding to foreign invaders, protecting delicate tissue. The F4/80 molecule plays a crucial role in 'immune privilege,' preventing inflammation and immune activation in privileged sites.
Researchers found TNF inhibits conversion of DHEAS to DHEA, leading to local androgen deficiency in RA patients. The study highlights the need for early anti-TNF antibody therapy in treating this inflammatory disease.
COPD researchers found a correlation between increased lung inflammation and reduced histone deacetylase activity, which may explain the disease's resistance to steroids. Low doses of theophylline, a tea leaf substance, could help restore HDAC activity and reverse resistance.
Research suggests that obesity can exacerbate asthma due to reduced lung function, chronic inflammation, and hormonal changes. The study found increased levels of pro-inflammatory hormones like leptin in obese individuals with asthma.